- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07563725
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging) (VAMP-Aging)
Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Eduardo Tibirica, MD, PhD
- Numéro de téléphone: +55-21-99914-6075
- E-mail: etibi@uol.com.br
Lieux d'étude
-
-
-
Rio de Janeiro, Brésil, 22240006
- Recrutement
- Eduardo Tibiriçá
-
Contact:
- Eduardo Tibiriçá, MD, PhD
- Numéro de téléphone: 21999146075
- E-mail: etibi@oul.com.br
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
La description
Inclusion Criteria:
- Absence of symptoms and history of cardiovascular and cerebrovascular diseases.
- Baseline blood pressure levels within the normal range (< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications.
Exclusion Criteria:
- Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents.
- Smoking: Active or quit less than 5 years ago.
- Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes.
- Surgery or trauma in the last 60 days.
- Renal Dysfunction: Chronic renal failure (estimated by eGFR < 60 mL/min/1.73m²).
- Medication Use: Chronic use of corticosteroids, immunosuppressants, or drugs with direct action on vascular reactivity (e.g., continuous use of nitrates).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
elderly (60-80 years)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
very elderly (>80)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
control group: healthy young people aged 20-40 years
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Systemic (cutaneous) microcirculatory reactivity.
Délai: up to 20 minutes
|
To analyze structural and functional changes in the microcirculation in different ages groups, with emphasis on microvascular endothelial senescence. |
up to 20 minutes
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Muscle Strength
Délai: up to 10 minutes
|
Handgrip Dynamometry Maximum isometric strength will be assessed using a manual hydraulic dynamometer. |
up to 10 minutes
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Eduardo Tibirica, MD, PhD, National Institute of Cardiology/Ministry of Health
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- VAMP-Aging
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .